News

07-14 10:40

Study of Klebsiella Pneumoniae Tetravalent Bioconjugate Vaccine (Kleb4V)

07-14 10:36

BinaxNOW™ COVID-19 IgG Rapid / BinaxNOW™ COVID-19 Antibody Self Test Study

07-14 10:31

Radiostereometry in the Assessment of Knee Prosthesis Study

07-07 12:28

Study of OnabotulinumtoxinA (BOTOX) for platysma prominence

07-07 12:22

Study of efficacy of CNP-201 in subjects with peanut allergy

07-07 11:07

Study of JB-101 to induce operational tolerance in living donor liver

06-30 18:26

Selective C-reactive protein apheresis in ST-elevation myocardial infarction study

06-30 18:20

Study of Isatuximab, bortezomib, lenalidomide, dexamethasone in multiple myeloma

06-30 18:10

Study of IV NTR-441 solution in healthy volunteers and COVID-19 patients

06-30 18:02

Urothelial Carcinoma clinical trial begins in United States

06-30 17:57

Long COVID clinical trial begins in United States.

06-26 08:43

Study of FB-401 in patients with atopic dermatitis

06-25 13:47

Study of Intravenous AMB-05X in Tenosynovial Giant Cell Tumor Patients

06-15 17:31

The trial of InterLeukin-7 in lymphopenic patients With COVID-19

06-15 17:26

Study of EDP1867 for moderate atopic dermatitis, moderate psoriasis, and/or mild asthma

06-15 16:13

The study of VIB7734 for the Treatment of Active Lupus Erythematosus

06-15 15:32

DreamKit Respiratory Effort Signal Validation Study

05-10 15:32

Clinical trial investigating OCT Guided vs COmplete Pci- in patients with infarction

05-10 14:01

Study to test Levothyroxine Formulation in Hypothyroid Patients

05-05 09:43

A SARS-CoV-2 Infection clinical trial begins in United States

05-05 09:32

BTL Industries Ltd started a new clinical trial for toning of buttocks

05-05 09:22

Study of (rATG) in patients preparing for bone marrow transplant

05-04 20:37

Study of semaglutide in diabetes with chronic kidney disease

05-03 21:02

AstraZeneca is testing Capivasertib + Palbociclib + Fulvestrant advanced breast cancer

05-02 13:57

National Cancer Institute (NCI) is evaluating Pembrolizumab / CMP-001 for operable melanoma.

Clinical Research News

Kommende kliniske forsøg

NCT04434937

Rekruttering

Open-label undersøgelse af Parsaclisib hos japanske deltagere med tilbagefald eller ildfast follikulært lymfom (CITADEL-213)

Betingelser: Lymfom
NCT03600883

Rekruttering

ensemble ami

Betingelser: ensemble ami
NCT04659161

Rekruttering

En undersøgelse til vurdering af effektiviteten og sikkerheden af KarXT hos akutpsykotiske indlagte voksne patienter med skizofreni (EMERGENT-2)

Betingelser: Schizophrenia, Skizofreni; Psykose
NCT04781322

Rekruttering

Sikkerhed, tolerance og bioeffekter af Alirocumab i ikke-behandling, der søger stærke drikkere

Betingelser: Alcohol Associated Liver Disease, Tung drikkeadfærd
NCT03514433

Rekruttering

Oversættelse af forskning til praksis

Betingelser: Kræft, bryst
NCT04612790

Rekruttering

En undersøgelse til undersøgelse af brugen af benralizumab hos patienter med bulløs pemfigoid.

Betingelser: Bulløs Pemphigoid
NCT04318717

Rekruttering

Pembrolizumab og hypofraktioneret strålebehandling til behandling af mucosal melanom

Betingelser: Slimhinde-melanom i hoved og nakke
NCT04583072

Rekruttering

Stockholm3 Valideringsundersøgelse i en multietnisk kohorte

Betingelser: Prostatakræft (diagnose)
NCT03329092

Rekruttering

En undersøgelse til bestemmelse af effektivitet, sikkerhed og tolerabilitet for Aztreonam-Avibactam (ATM-AVI) ± Metronidazol (MTZ) versus Meropenem (MER) ± Colistin (COL) til behandling af alvorlige infektioner på grund af gramnegativ bakterier.

Betingelser: Complicated Intra-abdominal Infection, Hosptial erhvervet lungebetændelse, Ventilatorassocieret lungebetændelse
NCT04216342

Rekruttering

Sikkerhed, tolerabilitet, farmakokinetik og farmakodynamik af Fx-5A hos raske frivillige

Betingelser: Kardiovaskulær sygdom

Recent CRA jobs